MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Phenylbutyric Acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Fluocinolone Acetonide.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Fluocinolone Acetonide.
Acemetacin
The risk or severity of adverse effects can be increased when Acemetacin is combined with Fluocinolone Acetonide.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluocinolone Acetonide.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Fluocinolone Acetonide.
Aldesleukin
Fluocinolone Acetonide may decrease the antineoplastic activities of Aldesleukin.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Fluocinolone Acetonide.
Aloxiprin
The risk or severity of adverse effects can be increased when Aloxiprin is combined with Fluocinolone Acetonide.
Aluminum
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Aluminium.
Aluminum Hydroxide
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Aluminum hydroxide.
Aluminum Magnesium Silicate
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Almasilate.
Ambenonium
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Ambenonium.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Aminosalicylic Acid is combined with Fluocinolone Acetonide.
Amiodarone
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Amiodarone.
Amphotericin B
Fluocinolone Acetonide may increase the hypokalemic activities of Amphotericin B.
amphotericin B liposomal
Fluocinolone Acetonide may increase the hypokalemic activities of Amphotericin B.
Anthrax immune globulin, human
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Anthrax immune globulin human.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Fluocinolone Acetonide.
Apalutamide
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Apalutamide.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Fluocinolone Acetonide.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Fluocinolone Acetonide.
Aprepitant
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Aprepitant.
Aspirin
The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fluocinolone Acetonide.
Atazanavir
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Atazanavir.
Atracurium Besylate
Atracurium besylate may increase the adverse neuromuscular activities of Fluocinolone Acetonide.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Fluocinolone Acetonide.
Azosemide
Fluocinolone Acetonide may increase the hypokalemic activities of Azosemide.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Fluocinolone Acetonide.
BCG Vaccine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with BCG vaccine.
BCG, Live, Connaught Strain
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Bacillus calmette-guerin substrain connaught live antigen.
BCG, Live, Tice Strain
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Bacillus calmette-guerin substrain tice live antigen.
Bendroflumethiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Bendroflumethiazide.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Fluocinolone Acetonide.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Fluocinolone Acetonide.
Bismuth Subcitrate
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Bismuth Subcitrate.
Boceprevir
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Boceprevir.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Fluocinolone Acetonide.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Fluocinolone Acetonide.
Bumetanide
Fluocinolone Acetonide may increase the hypokalemic activities of Bumetanide.
Calcitriol
The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluocinolone Acetonide.
Calcium Carbonate
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Calcium Carbonate.
Capromab Pendetide
Fluocinolone Acetonide may decrease effectiveness of Capromab pendetide as a diagnostic agent.
Carbamazepine
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Fluocinolone Acetonide.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Fluocinolone Acetonide.
Ceritinib
Fluocinolone Acetonide may increase the hyperglycemic activities of Ceritinib.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Fluocinolone Acetonide.
Chlorothiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Chlorothiazide.
Chlorotrianisene
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Chlorotrianisene.
Chlorthalidone
Fluocinolone Acetonide may increase the hypokalemic activities of Chlorthalidone.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Fluocinolone Acetonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluocinolone Acetonide.
Cinoxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Cinoxacin.
Clarithromycin
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Clarithromycin.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Fluocinolone Acetonide.
Cobicistat
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Cobicistat.
Colesevelam
Colesevelam can cause a decrease in the absorption of Fluocinolone Acetonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Fluocinolone Acetonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Corticorelin Ovine
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocinolone Acetonide.
Corticorelin Ovine Triflutate
The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocinolone Acetonide.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Fluocinolone Acetonide.
Cyclopenthiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Cyclopenthiazide.
Danazol
Fluocinolone Acetonide may increase the fluid retaining activities of Danazol.
Darunavir
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Darunavir.
Deferasirox
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Deferasirox.
Demecarium
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Demecarium.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fluocinolone Acetonide.
Dienestrol
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Dienestrol.
Diethylstilbestrol
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Diethylstilbestrol.
Diflunisal
The risk or severity of adverse effects can be increased when Diflunisal is combined with Fluocinolone Acetonide.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Fluocinolone Acetonide.
Distigmine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Distigmine.
Donepezil
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Donepezil.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Fluocinolone Acetonide.
Echothiophate
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Echothiophate.
Edrophonium
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Edrophonium.
Enoxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Enoxacin.
Enzalutamide
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Enzalutamide.
Equol, (-)-
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Equol.
Estradiol
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estradiol.
Estradiol acetate
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estradiol acetate.
Estradiol Cypionate
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estradiol cypionate.
Estradiol Valerate
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estradiol valerate.
Estriol
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estriol.
Estrogens, Conjugated (USP)
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Conjugated estrogens.
Estrogens, Esterified (USP)
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estrogens, esterified.
Estrone
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estrone.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Fluocinolone Acetonide.
Ethacrynate
Fluocinolone Acetonide may increase the hypokalemic activities of Etacrynic acid.
Ethacrynic Acid
Fluocinolone Acetonide may increase the hypokalemic activities of Etacrynic acid.
Ethinyl Estradiol
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Ethinyl Estradiol.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Fluocinolone Acetonide.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Fluocinolone Acetonide.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Fluocinolone Acetonide.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Fluocinolone Acetonide.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Fluocinolone Acetonide.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Fluocinolone Acetonide.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Fluocinolone Acetonide.
Ferulic Acid
The risk or severity of adverse effects can be increased when Ferulic acid is combined with Fluocinolone Acetonide.
Fleroxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Fleroxacin.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Fluocinolone Acetonide.
Flumequine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Flumequine.
Fluoxymesterone
Fluocinolone Acetonide may increase the fluid retaining activities of Fluoxymesterone.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fluocinolone Acetonide.
Fosaprepitant
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Fosphenytoin.
Furosemide
Fluocinolone Acetonide may increase the hypokalemic activities of Furosemide.
Galantamine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Gallamine Triethiodide.
Gatifloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Gatifloxacin.
Gatifloxacin Anhydrous
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Gatifloxacin.
Gemifloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Gemifloxacin.
Gemifloxacin Mesylate
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Gemifloxacin.
Genistein
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Genistein.
Ginkgo biloba extract
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Ginkgo biloba.
Glycerol Phenylbutyrate
The therapeutic efficacy of Glycerol Phenylbutyrate can be decreased when used in combination with Fluocinolone Acetonide.
Grepafloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Grepafloxacin.
Hepatitis A Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Hepatitis A Vaccine.
Hepatitis B Surface Antigen Vaccine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Hepatitis B Vaccine (Recombinant).
Hyaluronidase
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluocinolone Acetonide.
Hyaluronidase, Ovine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluocinolone Acetonide.
Hydrochlorothiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Hydrochlorothiazide.
Hydroflumethiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Hydroflumethiazide.
Hydrotalcite
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Hydrotalcite.
Hypoxis hemerocallidea root extract
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fluocinolone Acetonide.
Icatibant
The risk or severity of adverse effects can be increased when Icatibant is combined with Fluocinolone Acetonide.
Idelalisib
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Idelalisib.
Indacaterol
Indacaterol may increase the hypokalemic activities of Fluocinolone Acetonide.
Indapamide
Fluocinolone Acetonide may increase the hypokalemic activities of Indapamide.
Indinavir
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Indinavir.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Fluocinolone Acetonide.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Fluocinolone Acetonide.
Isoflurophate
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Isoflurophate.
Isoniazid
The serum concentration of Isoniazid can be decreased when it is combined with Fluocinolone Acetonide.
Itraconazole
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Itraconazole.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Fluocinolone Acetonide.
Ketoconazole
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Ketoconazole.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fluocinolone Acetonide.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Fluocinolone Acetonide.
Lacidipine
The serum concentration of Lacidipine can be decreased when it is combined with Fluocinolone Acetonide.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Fluocinolone Acetonide.
Levofloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Levofloxacin.
Levofloxacin Anhydrous
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Levofloxacin.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Fluocinolone Acetonide.
Lopinavir
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Lopinavir.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Fluocinolone Acetonide.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Fluocinolone Acetonide.
Lumacaftor
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Lumacaftor.
Magaldrate
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Magaldrate.
Magnesium Hydroxide
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Magnesium hydroxide.
Magnesium Oxide
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fluocinolone Acetonide.
Magnesium Trisilicate
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Magnesium Trisilicate.
Malathion
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Malathion.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Fluocinolone Acetonide.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluocinolone Acetonide.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fluocinolone Acetonide.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Fluocinolone Acetonide.
Mefloquine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Mefloquine.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Fluocinolone Acetonide.
Memantine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Memantine.
Mesalamine
The risk or severity of adverse effects can be increased when Mesalazine is combined with Fluocinolone Acetonide.
Mesterolone
Fluocinolone Acetonide may increase the fluid retaining activities of Mesterolone.
Mestranol
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Mestranol.
Methyclothiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Methyclothiazide.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Methyl salicylate is combined with Fluocinolone Acetonide.
Methyltestosterone
Fluocinolone Acetonide may increase the fluid retaining activities of Methyltestosterone.
Metoclopramide
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Metoclopramide.
Metolazone
Fluocinolone Acetonide may increase the hypokalemic activities of Metolazone.
Mifepristone
The therapeutic efficacy of Fluocinolone Acetonide can be decreased when used in combination with Mifepristone.
Minaprine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Minaprine.
Mitotane
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Mitotane.
Mivacurium
Mivacurium may increase the adverse neuromuscular activities of Fluocinolone Acetonide.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fluocinolone Acetonide.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Fluocinolone Acetonide.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fluocinolone Acetonide.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Fluocinolone Acetonide.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Fluocinolone Acetonide.
Nalidixic Acid
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Nalidixic Acid.
Nandrolone
Fluocinolone Acetonide may increase the fluid retaining activities of Nandrolone.
Nandrolone Decanoate
Fluocinolone Acetonide may increase the fluid retaining activities of Nandrolone decanoate.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Fluocinolone Acetonide.
Nefazodone
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Nelfinavir.
Neostigmine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Neostigmine.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Fluocinolone Acetonide.
Nevirapine
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Nevirapine.
Nicorandil
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Nicorandil.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Fluocinolone Acetonide.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Fluocinolone Acetonide.
Norfloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Norfloxacin.
O-PHENANTHROLINE
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with 1,10-Phenanthroline.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Fluocinolone Acetonide.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Fluocinolone Acetonide.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fluocinolone Acetonide.
Oxandrolone
Fluocinolone Acetonide may increase the fluid retaining activities of Oxandrolone.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Fluocinolone Acetonide.
Oxymetholone
Fluocinolone Acetonide may increase the fluid retaining activities of Oxymetholone.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Fluocinolone Acetonide.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Fluocinolone Acetonide.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Fluocinolone Acetonide.
Pefloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Pefloxacin.
Pentobarbital
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Pentobarbital.
Phenobarbital
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Phenobarbital.
Phenylacetic Acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Fluocinolone Acetonide.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Fluocinolone Acetonide.
Phenylbutyrate
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Fluocinolone Acetonide.
Phenytoin
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Phenytoin.
Physostigmine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Physostigmine.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluocinolone Acetonide.
Piretanide
Fluocinolone Acetonide may increase the hypokalemic activities of Piretanide.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Fluocinolone Acetonide.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Fluocinolone Acetonide.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Fluocinolone Acetonide.
Polyestradiol Phosphate
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Polyestradiol phosphate.
Polythiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Polythiazide.
Posaconazole
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Posaconazole.
Primidone
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Primidone.
Promestriene
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Promestriene.
Pyridostigmine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Pyridostigmine.
Pyridostigmine Bromide
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Pyridostigmine.
Quinestrol
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Quinestrol.
Quinethazone
Fluocinolone Acetonide may increase the hypokalemic activities of Quinethazone.
Rabies Immune Globulin, Human
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Human rabies virus immune globulin.
Rabies Virus Vaccine Flury-Lep Strain
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Rabies virus inactivated antigen, A.
Rapacuronium
Rapacuronium may increase the adverse neuromuscular activities of Fluocinolone Acetonide.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Fluocinolone Acetonide.
Rifabutin
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with Rifapentine.
Rivastigmine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Rivastigmine.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Fluocinolone Acetonide.
Rosoxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Rosoxacin.
ROTAVIRUS VACCINE, LIVE
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Rotavirus Vaccine.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Rubella virus vaccine.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Fluocinolone Acetonide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Salicylic acid is combined with Fluocinolone Acetonide.
Salmonella enterica subsp. enterica serovar typhi
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Salmonella typhi ty21a live antigen.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Fluocinolone Acetonide.
Saquinavir
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Saquinavir.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Fluocinolone Acetonide.
Sodium Bicarbonate
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Sodium bicarbonate.
Sparfloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Sparfloxacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Fluocinolone Acetonide can be decreased when it is combined with St. John's Wort.
Stanozolol
Fluocinolone Acetonide may increase the fluid retaining activities of Stanozolol.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fluocinolone Acetonide.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Fluocinolone Acetonide.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Fluocinolone Acetonide.
synthetic conjugated estrogens, A
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Synthetic Conjugated Estrogens, B.
Tacrine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Tacrine.
Telaprevir
The serum concentration of Telaprevir can be decreased when it is combined with Fluocinolone Acetonide.
Telithromycin
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Telithromycin.
Temafloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Temafloxacin.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Fluocinolone Acetonide.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluocinolone Acetonide.
Testosterone
Fluocinolone Acetonide may increase the fluid retaining activities of Testosterone.
Testosterone Enanthate
The risk or severity of edema formation can be increased when Testosterone enanthate is combined with Fluocinolone Acetonide.
Testosterone Propionate
Fluocinolone Acetonide may increase the fluid retaining activities of Testosterone propionate.
Testosterone Undecanoate
The risk or severity of fluid retention can be increased when Testosterone undecanoate is combined with Fluocinolone Acetonide.
Tetanus Toxoid Vaccine, Inactivated
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Clostridium tetani toxoid antigen (formaldehyde inactivated).
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Fluocinolone Acetonide.
Tibolone
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Tibolone.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Fluocinolone Acetonide.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Fluocinolone Acetonide.
Torsemide
Fluocinolone Acetonide may increase the hypokalemic activities of Torasemide.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Fluocinolone Acetonide.
Trichlormethiazide
Fluocinolone Acetonide may increase the hypokalemic activities of Trichlormethiazide.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Trolamine salicylate is combined with Fluocinolone Acetonide.
Tromethamine
The bioavailability of Fluocinolone Acetonide can be decreased when combined with Tromethamine.
Trovafloxacin
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Trovafloxacin.
Tubocurarine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Tubocurarine.
Typhoid Vaccine Live Ty21a
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Salmonella typhi ty21a live antigen.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Salmonella typhi ty2 vi polysaccharide antigen.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Fluocinolone Acetonide.
Varicella Virus Vaccine Live (Oka-Merck) strain
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Varicella Zoster Vaccine (Live/Attenuated).
Voriconazole
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Voriconazole.
Warfarin
Fluocinolone Acetonide may increase the anticoagulant activities of Warfarin.
Yellow Fever Vaccine
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Yellow Fever Vaccine.
Yellow-Fever Virus Vaccine, 17D-204 strain
The risk or severity of adverse effects can be increased when Fluocinolone Acetonide is combined with Yellow Fever Vaccine.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Fluocinolone Acetonide.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Fluocinolone Acetonide.
